In March 2025, the company declared new options for the immediate-to-buyer supplying of its Wegovy weight loss drug. The company founded a new pharmacy, identified as NovoCare, which would cost buyers $499 monthly for access to the drug, fewer than 50 % the cost of the drug by means of other pha